Systemic-exposure study of AN 2728 in patients with psoriasis.
Phase of Trial: Phase I
Latest Information Update: 09 Feb 2012
At a glance
- Drugs Crisaborole (Primary)
- Indications Psoriasis
- Focus Pharmacokinetics
- 09 Feb 2012 Status changed from recruiting to completed, according to an Anacor Pharmaceuticals media release.
- 07 Feb 2012 Results were reported in an Anacor Pharmaceuticals media release.
- 22 Nov 2011 Results are expected in early 2012.